Antiatherothrombotic properties of statins: implications for cardiovascular event reduction
RS Rosenson, CC Tangney - Jama, 1998 - jamanetwork.com
Clinical trials of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors or
statin therapy have demonstrated that baseline or treated low-density lipoprotein (LDL) …
statin therapy have demonstrated that baseline or treated low-density lipoprotein (LDL) …
[引用][C] Antiatherothrombotic Properties of Statins
RS Rosenson, CC Tangney - JAMA, 1998 - cir.nii.ac.jp
Antiatherothrombotic Properties of Statins | CiNii Research CiNii 国立情報学研究所 学術情報
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本を …
ナビゲータ[サイニィ] 詳細へ移動 検索フォームへ移動 論文・データをさがす 大学図書館の本を …
Antiatherothrombotic properties of statins: implications for cardiovascular event reduction.
RS Rosenson, CC Tangney - JAMA, 1998 - europepmc.org
Clinical trials of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors or
statin therapy have demonstrated that baseline or treated low-density lipoprotein (LDL) …
statin therapy have demonstrated that baseline or treated low-density lipoprotein (LDL) …
Antiatherothrombotic properties of statins: implications for cardiovascular event reduction
RS Rosenson, CC Tangney - JAMA, 1998 - pubmed.ncbi.nlm.nih.gov
Clinical trials of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors or
statin therapy have demonstrated that baseline or treated low-density lipoprotein (LDL) …
statin therapy have demonstrated that baseline or treated low-density lipoprotein (LDL) …
[PDF][PDF] Antiatherothrombotic Properties of Statins
RS Rosenson, CC Tangney - JAMA, 1998 - academia.edu
Clinical trials of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors or
statin therapy have demonstrated that baseline or treated lowdensity lipoprotein (LDL) …
statin therapy have demonstrated that baseline or treated lowdensity lipoprotein (LDL) …
[PDF][PDF] Antiatherothrombotic Properties of Statins
RS Rosenson, CC Tangney - JAMA, 1998 - researchgate.net
Clinical trials of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors or
statin therapy have demonstrated that baseline or treated lowdensity lipoprotein (LDL) …
statin therapy have demonstrated that baseline or treated lowdensity lipoprotein (LDL) …
Antiatherothrombotic properties of statins.
RS Rosenson, CC Tangney - JAMA: Journal of the American …, 1998 - search.ebscohost.com
Discusses the clinical trials of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA)
reductase inhibitors, or statin therapy. Weak association between treated low-density …
reductase inhibitors, or statin therapy. Weak association between treated low-density …
[引用][C] Antiatherothrombotic properties of statins: Implications for cardiovascular event reduction
RS ROSENSON, CC TANGNEY - JAMA, the journal of the …, 1998 - pascal-francis.inist.fr
Antiatherothrombotic properties of statins: Implications for cardiovascular event reduction
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …
CNRS Inist Pascal-Francis CNRS Pascal and Francis Bibliographic Databases Simple …